4/A

PRIMARY DOCUMENT

Company: GALECTIN THERAPEUTICS INC
Filed: July 27, 2011
Period of Report: March 31, 2011
Accession Number: 0001453356-11-000008

View Document ↗ View on SEC.gov ↗